Raised limb bands developing in infancy.

Raised limb bands developing in infancy. Br J Dermatol (2002) 1.49

Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell (1991) 3.49

Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum Mol Genet (2001) 2.95

Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet (2000) 2.85

Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation (1998) 2.21

Kwashiorkor in the United States: fad diets, perceived and true milk allergy, and nutritional ignorance. Arch Dermatol (2001) 1.66

Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy (2011) 1.59

The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell (1992) 1.51

Treatment of cutaneous hemangiomas by the flashlamp-pumped pulsed dye laser: prospective analysis. J Pediatr (1992) 1.46

Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature. J Am Acad Dermatol (1998) 1.44

Drug administration to the pregnant or lactating woman: a reference guide for dermatologists. J Am Acad Dermatol (1990) 1.43

Juvenile dermatomyositis presenting with rash alone. Pediatrics (1997) 1.42

Response of deep tufted angioma to interferon alfa. J Am Acad Dermatol (1995) 1.39

Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by cidofovir. Pediatr Transplant (2010) 1.39

Pseudoporphyria cutanea tarda: two case reports on children receiving peritoneal dialysis and erythropoietin therapy. J Pediatr (1992) 1.38

Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol (1999) 1.34

A missense mutation in the zinc-finger domain of the human hairless gene underlies congenital atrichia in a family of Irish travellers. Am J Hum Genet (1998) 1.32

Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol (1998) 1.28

Localized facial flushing in infancy. Auriculotemporal nerve (Frey) syndrome. Arch Dermatol (1997) 1.22

The role of filaggrin in the atopic diathesis. Clin Exp Allergy (2010) 1.18

Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations. Br J Dermatol (2011) 1.17

Cutaneous changes associated with inflammatory bowel disease. Pediatr Dermatol (1986) 1.16

A novel KIT mutation results in piebaldism with progressive depigmentation. J Am Acad Dermatol (2001) 1.13

Rat bite fever in a pet lover. J Am Acad Dermatol (1998) 1.09

Aquagenic palmoplantar keratoderma. J Am Acad Dermatol (2001) 1.09

Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism. J Invest Dermatol (1991) 1.06

Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation. Glycobiology (2001) 1.02

Primary generalized and localized hypertrichosis in children. Arch Dermatol (2001) 1.01

A novel mutation in KRT12 associated with Meesmann's epithelial corneal dystrophy. Br J Ophthalmol (2002) 1.00

Identification of novel mutations in basic hair keratins hHb1 and hHb6 in monilethrix: implications for protein structure and clinical phenotype. J Invest Dermatol (1999) 0.99

Full-thickness surgical excision for the treatment of inflammatory linear verrucous epidermal nevus. Ann Plast Surg (2001) 0.99

Childhood rosacea. Pediatr Dermatol (1992) 0.98

A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1985) 0.98

Localization of the alpha 3 (V) chain of type V collagen in human skin. J Invest Dermatol (1987) 0.97

Consequences of seven novel mutations on the expression and structure of keratinocyte transglutaminase. J Biol Chem (1997) 0.96

Pustulosis palmaris et plantaris: its association with chronic recurrent multifocal osteomyelitis. J Am Acad Dermatol (1985) 0.94

Knuckle pads in children. Am J Dis Child (1986) 0.94

A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol (2007) 0.93

Disseminated Fusarium solani infection with cutaneous nodules in a bone marrow transplant patient. Int J Dermatol (1988) 0.92

What syndrome is this? Ankyloblepharon-ectodermal defects--cleft lip and palate (Hay-Wells) syndrome. Pediatr Dermatol (1998) 0.92

Langerhans cell histiocytosis presenting in the neonatal period: a retrospective case series. Arch Pediatr Adolesc Med (2001) 0.92

Hodgkin's disease manifesting as prurigo nodularis. Pediatr Dermatol (1990) 0.91

Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Br J Dermatol (2006) 0.91

Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis. Correlation between location and disease severity. J Clin Invest (1994) 0.91

What syndrome is this? CHIME syndrome. Pediatr Dermatol (2001) 0.90

Cracks in the foundation: keratin filaments and genetic disease. Trends Cell Biol (1994) 0.90

Guidelines of care for neurofibromatosis type 1. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol (1997) 0.90

Dermolytic (dystrophic) epidermolysis bullosa inversa. Arch Dermatol (1988) 0.90

Sarcoidosis in children: differentiation from juvenile rheumatoid arthritis. Pediatr Dermatol (1987) 0.87

Association of facial hemangiomas with Dandy-Walker and other posterior fossa malformations. J Pediatr (1993) 0.87

Inhibition of integrin-linked kinase/protein kinase B/Akt signaling: mechanism for ganglioside-induced apoptosis. J Biol Chem (2001) 0.86

Association between long-term acitretin therapy and osteoporosis: no evidence of increased risk. Clin Exp Dermatol (2003) 0.86

Hemorrhagic pityriasis rosea: an unusual variant. Pediatrics (1982) 0.86

Carbohydrate-carbohydrate binding of ganglioside to integrin alpha(5) modulates alpha(5)beta(1) function. J Biol Chem (2000) 0.85

Itraconazole pulse therapy for dermatophyte onychomycosis in children. Arch Pediatr Adolesc Med (2000) 0.85

Congenital rhabdoid sarcoma with cutaneous metastases. J Am Acad Dermatol (1990) 0.84

Restoration of open reading frame resulting from skipping of an exon with an internal deletion in the COL7A1 gene. Lab Invest (1998) 0.84

Vitamin D deficiency and rickets in children and adolescents with ichthyosiform erythroderma in type IV and V skin. Br J Dermatol (2012) 0.83

Chemiluminescence detection of gangliosides by thin-layer chromatography. J Lipid Res (1995) 0.83

Organ-specific, phylogenetic, and ontogenetic distribution of the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1986) 0.83

LAMB3 mutations in generalized atrophic benign epidermolysis bullosa: consequences at the mRNA and protein levels. Lab Invest (1998) 0.83

Severe infantile epidermolysis bullosa simplex. Dowling-Meara type. Arch Dermatol (1986) 0.83

Prenatal diagnosis for recessive dystrophic epidermolysis bullosa in 10 families by mutation and haplotype analysis in the type VII collagen gene (COL7A1). Mol Med (1996) 0.83

Clinical pearl: use of self-adhesive, compressive wraps in the treatment of limb hemangiomas. J Am Acad Dermatol (1995) 0.83

Cutaneous sarcoidosis associated with sarcoidosis of the upper airway. Arch Dermatol (1983) 0.83

Development of mycosis fungoides after bone marrow transplantation for chronic myeloid leukaemia: transmission from an allogeneic donor. Br J Dermatol (2014) 0.83

Elastase and neutral cathepsin production by human fibroblasts: effect of culture conditions on synthesis and secretion. J Invest Dermatol (1986) 0.82

Primary cutaneous adenoid cystic carcinoma. Clin Exp Dermatol (1996) 0.82

In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model. J Invest Dermatol (1999) 0.82

Atypical epidermolytic palmoplantar keratoderma presentation associated with a mutation in the keratin 1 gene. Br J Dermatol (2004) 0.82

Mutations in keratin K9 in kindreds with epidermolytic palmoplantar keratoderma and epidemiology in Northern Ireland. J Invest Dermatol (1998) 0.82

Squaric acid immunotherapy for warts in children. J Am Acad Dermatol (2000) 0.82

Hedgehog hives. Arch Dermatol (1999) 0.81

Management of difficult and severe eczema in childhood. BMJ (2012) 0.81

Ganglioside modulates ligand binding to the epidermal growth factor receptor. J Invest Dermatol (2001) 0.81

A disease resembling junctional epidermolysis bullosa in a toy poodle. Am J Dermatopathol (1988) 0.81

Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo. Cancer Res (1997) 0.81

Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial. Br J Dermatol (2007) 0.81

Langerhans cell histiocytosis and dermatophytosis. J Am Acad Dermatol (1993) 0.81

Familial multiple cafe au lait spots. Arch Dermatol (1994) 0.80

Integrin alpha 5 beta 1 expression is required for inhibition of keratinocyte migration by ganglioside GT1b. Exp Cell Res (1998) 0.80

Histology of lipoid proteinosis. JAMA (1994) 0.80

Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol (1998) 0.80

A mutation detection strategy for the human keratin 6A gene and novel missense mutations in two cases of pachyonychia congenita type 1. Exp Dermatol (1999) 0.79

What syndrome is this? Congenital Kasabach-Merritt syndrome. Pediatr Dermatol (1994) 0.79

Ocular surface reconstruction in LOGIC syndrome by amniotic membrane transplantation. Cornea (2001) 0.79

Carney complex: report of a kindred with predominantly cutaneous manifestations. Br J Dermatol (1997) 0.78

Cutaneous Fusarium infection in an adolescent with acute leukemia. Pediatr Dermatol (1992) 0.78

Chediak-Higashi syndrome in a black child. Pediatr Dermatol (1992) 0.78

The treatment of viral warts with topical cidofovir 1%: our experience of seven paediatric patients. Br J Dermatol (2008) 0.77

Pseudoporphyria induced by mefenamic acid. Br J Dermatol (1998) 0.77

The generalized atrophic benign form of junctional epidermolysis bullosa. Experience with four patients in the United States. Arch Dermatol (1986) 0.77

Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus. Arch Dermatol (1999) 0.76

Inhibitory action of ganglioside GM3 on murine neuroblastoma cell proliferation: modulating effect of fetal calf serum. Anticancer Res (1995) 0.76

Cimetidine for the treatment of warts. West J Med (1996) 0.76

Dermatologic uses of methotrexate in children: indications and guidelines. Pediatr Dermatol (1985) 0.76

Mucocutaneous manifestations of the hyper-IgM immunodeficiency syndrome. J Am Acad Dermatol (1998) 0.76

Expanding our concepts of mosaic disorders of skin. Arch Dermatol (2001) 0.76

Two cases of incontinentia pigmenti simulating child abuse. Pediatrics (1997) 0.75

Miliary neonatal hemangiomatosis with fulminant heart failure and cardiac septal hypertrophy in two infants. Pediatr Dermatol (2004) 0.75

Ongoing blistering in a boy with congenital erosive and vesicular dermatosis healing with reticulated supple scarring. J Am Acad Dermatol (2001) 0.75